Adverse effects on risk of ischaemic heart disease of adding sugar to hot beverages in hypertensives using diuretics: A six year follow-up in the Copenhagen male study

Blood Pressure

Volumn 5, Issue 2, 1996, Pages 91-97

  Suadicani, P ^a   Hein, H O ^a,b   Gyntelberg, F ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Diuretics; Epidemiology; Hypertension; Insulin resistance syndrome; Ischaemic heart disease; Risk; Sugar

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; SUGAR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; COFFEE; DENMARK; DIETARY SUCROSE; DIURETICS; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; TEA;

EID: 0029883601     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609062114     Document Type: Article

References (23)

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
2. Warram JH, Laffel LM. Valsania P et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991; 152: 1093-4.
3. Ramsay LE, Yeo WW, Jackson PR. Diabetes, impaired glucose tolerance and insulin resistance with diuretics. Eur Heart J 1992; 13 (suppl G): 68-71.
4. Black HR. Metabolic considerations in the choice of therapy for the patient with hypertension. Am Heart J 1991; 121: 707-15.
5. Gyntelberg F. Physical fitness and coronary heart disease in male residents in Copenhagen aged 40 - 59. Dan Med Bull 1973; 20: 1-4.
6. Gyntelberg F. One- and two-years incidence of myocardial infarction in Copenhagen males aged 40 - 59. Dan Med Bull 1975; 22: 81-4.
7. Svalastoga K. Prestige, class and mobility. Copenhagen: Munksgaard, 1959.
8. Suadicani P, Hein HO, Gyntelberg F. Are social inequalities as associated with the risk of ischaemic heart disease a result of psychosocial working conditions? Atherosclerosis 1993; 101: 165-75.
9. Suadicani P, Hein HO, Gyntelberg F. Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease: the Copenhagen Male Study - 4 years' follow-up. Int J Epidemiol 1994; 23: 293-300.
10. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet 1964; i: 296-300.
11. Friedewald WT, Levy J, Friedrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-509.
12. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiological research. Principles and quantitative methods. London: Lifetime Learning Publications, 1982: chapter 19.
13. Norusis M. SPSS/PC+ Base Manual, Chicago, Illinois, USA. 1988.
14. Norusis M. SPSS/PC+ Advanced Manual, Chicago, Illinois, USA, 1988.
15. La Vecchia C, Francheschi S, Dolara P. Bidoli E, Barbone F. Refined-sugar intake and the risk of colorectal cancer in humans, Int J Cancer 1993; 55: 386-9.
16. Carlsen JE, Kober L, Torp-Pedersen C et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300: 975-8
17. Yudkin J. Sugar consumption and myocardial infarction. Lancet 1971; i 296-7.
18. Yudkin J. Sugar and disease. Nature 1972; 239: 197-9.
19. Shrapnel WS, Calvert GD, Nestel PJ, Truswell AS. Diet and coronary heart disease. Med J Aust 1992; Suppl 156: 9-16.
20. Reaven GM. Relationship between insulin resistance and hypertension. Diabetes Care 1991; 14 (Suppl 4): 33-8.
21. Lithell HO. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991; 14: 203-9.
22. Daae LN, Kierulff P, Landaas S, Urdal P. Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis. Scand J Clin Lab Invest 1993; Suppl 215: 19-27.
23. Tobian L, Brunner HR, Cohn JN et al. Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. AJH 1994; 7: 859-72.